Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) for the management of nonalcoholic fatty liver disease (NAFLD): A systematic review. The gene discussed is GCG; the disease is metabolic dysfunction-associated steatotic liver disease.